PubMed HealthSearch

Biomedical subjects

F Havlát

Publications and source records attributed to F Havlát.

8 recordsLinked to original sources

[Clinical use of infusion pumps with rotors in occlusive tracts].

The authors used in clinical practice an infusion pump driven by a rotation system with an occlusive pathway whereby the movement of the rotor is ensured by a stepper with reduction of the steps to 12,800 microsteps per revolution. As regards the degree of mechanical damage of the inserted tube of the infusion set this system did not differ from the keyboard system which is used by the majority of manufacturers as the driving unit of infusion pumps. Mechanical damage of the infusion set made from PVC was evaluated by the authors with regard to the amount of phthalic acid extracts which are added to PVC as softening agents and are not chemically linked. The authors recorded an increase of the temperature of the infusion solution during the flow through the driving unit in both investigated systems, however, the increase was smaller in the keyboard system. The increase of temperature was, however, in both instances small and has no impact on clinical practice. Contrary to the infusion pump with the keyboard system, the infusion pump with a rotor in an occlusive pathway and a microstep motor (12,800 microsteps per revolution) was significantly more accurate as regards dosage (evaluated as the difference between the required and actually achieved value of flow). The revealed difference was statistically significant at the 1% level. This greater precision of dosage can be ascribed to the point compression of the inserted and to the microvibrations transmitted from the rotor to the inserted tube of the infusion set which helps to recover after every compression the original volume (circular shape of section) of the inserted tube.

Diethylhexyl Phthalate

[Phthalic acid esters in the peritoneal cavity of patients treated with continuous ambulatory peritoneal dialysis].

A solution for peritoneal dialysis stored in bags made from material which does not contain diethylhexyl phthalate is significantly less contaminated with this plasticizer, as compared with a solution stored in bags made from PVC with diethylhexyl phthalate. The afferent tube which contains diethylhexyl phthalate in all sets investigated by the authors is not an important source of this plasticizer for the peritoneal solution. Contamination of the peritoneal solution with dibutyl phthalate added to colours used for print on the bags (inscription on the outside of the bag) was found in both types of bags (no significant differences were found). It may be thus assumed that dibutyl phthalate penetrates through the wall of both types of bags with the same intensity. This applies only, provided that the peritoneal solution is not contaminated with dibutyl phthatate during preparation, before it is filled into bags. After six hours instillation in the peritoneal cavity diethylhexyl phthalate and dibutyl phthalate was not detectable in the peritoneal solution (detection limit 0.5 microgram/l). They are completely retained and metabolized resp. in the patient's peritoneal cavity.

Ascitic Fluid